Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2022	Mar. 31, 2022
ASSETS
Cash and cash equivalents	$ 8,717	$ 7,670
Restricted cash and cash equivalents	1,849	2,065
Investments in marketable securities	4,571	4,953
Finance receivables, net of allowance for credit losses of $1,248 and $1,246	84,822	82,432
Investments in operating leases, net	33,703	35,455
Other assets	2,470	2,466
Total assets	136,132	135,041
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	110,423	109,152
Deferred income taxes	1,403	1,564
Other liabilities	6,061	6,224
Total liabilities	117,887	116,940
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at June 30, 2022 and March 31, 2022	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(47)	(21)
Retained earnings	17,375	17,205
Total shareholder's equity	18,245	18,101
Total liabilities and shareholder's equity	$ 136,132	$ 135,041